TD Waterhouse Canada’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16K | Hold |
327
| – | – | ﹤0.01% | 1793 |
|
|
2025
Q1 | $621 | Sell |
327
-98,291
| -100% | -$187K | ﹤0.01% | 1781 |
|
|
2024
Q4 | $187K | Buy |
98,618
+8,000
| +9% | +$15.2K | ﹤0.01% | 811 |
|
|
2024
Q3 | $115K | Buy |
90,618
+65
| +0.1% | +$82 | ﹤0.01% | 864 |
|
|
2024
Q2 | $90.2K | Buy |
90,553
+50,000
| +123% | +$49.8K | ﹤0.01% | 908 |
|
|
2024
Q1 | $79.9K | Hold |
40,553
| – | – | ﹤0.01% | 955 |
|
|
2023
Q4 | $75.5K | Hold |
40,553
| – | – | ﹤0.01% | 865 |
|
|
2023
Q3 | $57.9K | Hold |
40,553
| – | – | ﹤0.01% | 887 |
|
|
2023
Q2 | $45.7K | Buy |
40,553
+39,000
| +2,511% | +$44K | ﹤0.01% | 950 |
|
|
2023
Q1 | $1.16K | Hold |
1,553
| – | – | ﹤0.01% | 1581 |
|
|
2022
Q4 | $1.26K | Hold |
1,553
| – | – | ﹤0.01% | 1540 |
|
|
2022
Q3 | $633 | Hold |
1,553
| – | – | ﹤0.01% | 1609 |
|
|
2022
Q2 | $746 | Hold |
1,553
| – | – | ﹤0.01% | 1640 |
|
|
2022
Q1 | $1.26K | Buy |
1,553
+262
| +20% | +$212 | ﹤0.01% | 1645 |
|
|
2021
Q4 | $3.87K | Buy |
+1,291
| New | +$3.87K | ﹤0.01% | 1491 |
|